# OyaGen Inc.: Form D filings

OyaGen Inc., a biotechnology company in Rochester, NY, filed 3 Form D notices with the SEC between 2009 and 2017. The latest, on December 12, 2017, reports $345,000 sold of a $700,000 offering to 11 investors.

Find out what OyaGen Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20OyaGen%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=OyaGen%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Foyagen-inc-1319956)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20OyaGen%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=OyaGen%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Foyagen-inc-1319956)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: Rochester BioVenture Center, 77 Ridgeland Road, Rochester, NY, 14623
- Phone: (585) 697-4351
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1319956

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 12, 2017 | New notice | $700,000 | $345,000 | $355,000 | 11 | Nov 29, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1319956/000131995617000003/0001319956-17-000003-index.htm) |
| Oct 11, 2012 | New notice | $3,000,000 | $1,742,315 | $1,257,685 | 10 | Sep 28, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1319956/000131995612000002/0001319956-12-000002-index.htm) |
| Sep 17, 2009 | Amendment | $1,500,000 | $1,029,709 | $470,291 | 12 | Aug 20, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1319956/000131995609000004/0001319956-09-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Ryan Bennett | Executive Officer |  |
| Richard McCloskey | Director |  |
| Thomas Fitzgerald | Executive Officer, Promoter |  |
| Richard Ogden | Director |  |
| Harold Smith | Executive Officer, Director, Promoter |  |
| Roscoe Moore | Director |  |
| Kevin Phelps | Executive Officer, Director |  |
| Jose Coronas | Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of Dec 11, 2017](https://specstream.ai/data/form-d/week/2017-12-11) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what OyaGen Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).